Cargando…

Patient attitudes toward and goals for MDD treatment: a survey study

Background/Objectives: Major depressive disorder (MDD) is a highly prevalent disorder, frequently diagnosed and treated in a primary care setting; however, little information is available about the treatment decision-making process between MDD patients and their providers. A shared decision-making a...

Descripción completa

Detalles Bibliográficos
Autores principales: McNaughton, Emily C, Curran, Christopher, Granskie, Jamie, Opler, Mark, Sarkey, Sara, Mucha, Lisa, Eramo, Anna, François, Clement, Webber-Lind, Briana, McCue, Maggie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584170/
https://www.ncbi.nlm.nih.gov/pubmed/31354249
http://dx.doi.org/10.2147/PPA.S204198
_version_ 1783428479667142656
author McNaughton, Emily C
Curran, Christopher
Granskie, Jamie
Opler, Mark
Sarkey, Sara
Mucha, Lisa
Eramo, Anna
François, Clement
Webber-Lind, Briana
McCue, Maggie
author_facet McNaughton, Emily C
Curran, Christopher
Granskie, Jamie
Opler, Mark
Sarkey, Sara
Mucha, Lisa
Eramo, Anna
François, Clement
Webber-Lind, Briana
McCue, Maggie
author_sort McNaughton, Emily C
collection PubMed
description Background/Objectives: Major depressive disorder (MDD) is a highly prevalent disorder, frequently diagnosed and treated in a primary care setting; however, little information is available about the treatment decision-making process between MDD patients and their providers. A shared decision-making and goal attainment approach to establishing and tracking progress toward treatment goals that are meaningful to individual patients is explored in this survey study. In addition, information about patient perspectives on setting treatment goals, medication selection/switching, and engaging patients with their health care professionals was also collected and evaluated. Methods: A 50-question online survey was administered to members of the PatientsLikeMe community who indicated an MDD diagnosis and a switch in antidepressant medications within the past 2 years. Follow-up interviews were also conducted with a small subset of these participants. Results: Of the 200 participants who completed the survey, 42% reported currently having goals for MDD treatment. These goals were typically in the areas of physical health (62.7%), cognitive functioning (60.2%), and social aspects of life (57.8%). A majority of survey participants (61%) believed the goal attainment approach would be helpful to set and evaluate treatment goals. Conclusions: The data provide important insights into patient perspectives on the development of formal treatment plans and goals for MDD. In addition, the data also support the use of a patient-centric approach to shared decision-making by using a goal attainment scale to establish and track progress toward treatment goals that are meaningful to MDD patients in real-world clinical practice. The results of this study can be used to inform best practices in patient–clinician communication when developing an MDD treatment plan and goals.
format Online
Article
Text
id pubmed-6584170
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-65841702019-07-26 Patient attitudes toward and goals for MDD treatment: a survey study McNaughton, Emily C Curran, Christopher Granskie, Jamie Opler, Mark Sarkey, Sara Mucha, Lisa Eramo, Anna François, Clement Webber-Lind, Briana McCue, Maggie Patient Prefer Adherence Original Research Background/Objectives: Major depressive disorder (MDD) is a highly prevalent disorder, frequently diagnosed and treated in a primary care setting; however, little information is available about the treatment decision-making process between MDD patients and their providers. A shared decision-making and goal attainment approach to establishing and tracking progress toward treatment goals that are meaningful to individual patients is explored in this survey study. In addition, information about patient perspectives on setting treatment goals, medication selection/switching, and engaging patients with their health care professionals was also collected and evaluated. Methods: A 50-question online survey was administered to members of the PatientsLikeMe community who indicated an MDD diagnosis and a switch in antidepressant medications within the past 2 years. Follow-up interviews were also conducted with a small subset of these participants. Results: Of the 200 participants who completed the survey, 42% reported currently having goals for MDD treatment. These goals were typically in the areas of physical health (62.7%), cognitive functioning (60.2%), and social aspects of life (57.8%). A majority of survey participants (61%) believed the goal attainment approach would be helpful to set and evaluate treatment goals. Conclusions: The data provide important insights into patient perspectives on the development of formal treatment plans and goals for MDD. In addition, the data also support the use of a patient-centric approach to shared decision-making by using a goal attainment scale to establish and track progress toward treatment goals that are meaningful to MDD patients in real-world clinical practice. The results of this study can be used to inform best practices in patient–clinician communication when developing an MDD treatment plan and goals. Dove 2019-06-14 /pmc/articles/PMC6584170/ /pubmed/31354249 http://dx.doi.org/10.2147/PPA.S204198 Text en © 2019 McNaughton et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
McNaughton, Emily C
Curran, Christopher
Granskie, Jamie
Opler, Mark
Sarkey, Sara
Mucha, Lisa
Eramo, Anna
François, Clement
Webber-Lind, Briana
McCue, Maggie
Patient attitudes toward and goals for MDD treatment: a survey study
title Patient attitudes toward and goals for MDD treatment: a survey study
title_full Patient attitudes toward and goals for MDD treatment: a survey study
title_fullStr Patient attitudes toward and goals for MDD treatment: a survey study
title_full_unstemmed Patient attitudes toward and goals for MDD treatment: a survey study
title_short Patient attitudes toward and goals for MDD treatment: a survey study
title_sort patient attitudes toward and goals for mdd treatment: a survey study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584170/
https://www.ncbi.nlm.nih.gov/pubmed/31354249
http://dx.doi.org/10.2147/PPA.S204198
work_keys_str_mv AT mcnaughtonemilyc patientattitudestowardandgoalsformddtreatmentasurveystudy
AT curranchristopher patientattitudestowardandgoalsformddtreatmentasurveystudy
AT granskiejamie patientattitudestowardandgoalsformddtreatmentasurveystudy
AT oplermark patientattitudestowardandgoalsformddtreatmentasurveystudy
AT sarkeysara patientattitudestowardandgoalsformddtreatmentasurveystudy
AT muchalisa patientattitudestowardandgoalsformddtreatmentasurveystudy
AT eramoanna patientattitudestowardandgoalsformddtreatmentasurveystudy
AT francoisclement patientattitudestowardandgoalsformddtreatmentasurveystudy
AT webberlindbriana patientattitudestowardandgoalsformddtreatmentasurveystudy
AT mccuemaggie patientattitudestowardandgoalsformddtreatmentasurveystudy